Computer analysis of regulation of hepatocarcinoma marker genes hypermethylated by HCV proteins

Е. А. Ощепкова, Т. М. Хлебодарова, П. С. Деменков, A. S. Venzel, Nikita V. Ivanisenko, Alexandr D. Gavrilenko, Timofey Ivanisenko, A. V. Adamovskaya, Polina M. Revva, Inna N. Lavrik, В. А. ИванисенкоVavilov 2023 · DOI

This study, published in the Vavilov Journal of Genetics and Breeding, explores the molecular "wiring diagram" between the Hepatitis C Virus (HCV) and the development of liver cancer. By using advanced bioinformatic text-mining, researchers mapped how specific viral proteins hijack human transcription factors to regulate genes that are already known to be silenced in cancer, revealing a "double hit" mechanism of oncogenesis.

TL;DR

Researchers used the ANDSystem bioinformatic tool to discover that HCV proteins don't just wait for host cells to become cancerous; they actively manipulate the expression of 32 key liver cancer biomarkers. The study identifies the viral protein NS3 as a central hub that disrupts multiple tumor-suppressor pathways, providing new potential targets for drug development.

What Problem Does This Paper Address?

Hepatocellular carcinoma (HCC) is a leading cause of cancer death globally, and HCV infection is a major risk factor. We know that "epigenetic" changes—specifically DNA hypermethylation, where methyl groups are added to DNA to turn genes off—are hallmarks of HCC.

However, the specific functional links between viral proteins and these methylated marker genes have been fuzzy. The authors sought to bridge this gap: If a gene is a known marker for HCC because it is hypermethylated (silenced), do HCV proteins play a direct role in regulating that same gene through other pathways? Understanding this "cross-talk" is vital for finding pharmacological targets that can stop virus-induced cancer before it takes hold.

Methods

The researchers employed a "dry lab" approach using the ANDSystem (Associative Network Discovery System). This isn't just a static database; it’s a software package that uses text-mining to extract over 40 million facts from scientific literature and factual databases.

  1. Pathway Reconstruction: They defined seven distinct interaction patterns (P1–P7). These ranged from simple protein-protein interactions (PPI) to complex chains where a viral protein binds a human transcription factor (TF), which then regulates a target gene's expression.
  2. Statistical Filtering: They used a hypergeometric distribution to determine which of these patterns were statistically significant compared to a random set of genes.
  3. Network Analysis: Once the significant pathways were identified, they reconstructed the gene networks to see which viral proteins were the most "influential" in the system.

Datasets

  • Target Genes: A curated list of 32 hypermethylated genes identified from genome-wide studies as HCC markers (e.g., MGMT, SOCS1, TP53, WT1).
  • Viral Proteins: 10 proteins from the HCV proteome.
  • Knowledge Base: The ANDSystem's repository of molecular-genetic interactions.
  • Control Group: A standardized set of genes (Hoshida et al., 2008) used to validate the statistical significance of the findings.

Key Insights and Ideas

  • The "Double Hit" Hypothesis: The most striking insight is that HCV proteins influence genes that are already suppressed by methylation. By also inhibiting the transcription of these genes, the virus ensures these tumor suppressors are completely offline.
  • NS3 as the Master Regulator: The HCV protein NS3 (p70) emerged as the most active player, interacting with the largest number of expression regulators. It was linked to the regulation of five different tumor-suppressor genes, suggesting it is the primary "hijacker" in the HCV-HCC transition.
  • Transcription Factor Hijacking: The virus doesn't interact with DNA directly; it uses "middlemen." Viral proteins like Core, NS5B, and NS3 bind to human transcription factors such as NR4A1, STAT3, and JUN. For example, six different viral proteins were found to interact with NR4A1 to suppress the RUNX3 gene (a tumor suppressor) while activating WT1 (which can promote tumor growth).
  • Multidirectional Regulation: The regulation isn't just one-way. While the virus suppresses many "good" genes (oncosuppressors), it also appears to activate others, like TERT (telomerase), which helps cancer cells achieve immortality by preventing cell death.

Key Results

  • Pattern P4 was the winner: Only the pathway involving [Viral Protein → Human TF → Target Gene → Protein] was statistically significant (p-val = 0.0054; FDR = 0.032).
  • High Viral Involvement: 8 out of 10 HCV proteins were found to be active participants in these regulatory pathways.
  • Specific Gene Targets: The analysis identified 9 marker genes (DAPK1, SOCS1, MGMT, RASSF1, RUNX3, TP53, WIF1, WT1, and TERT) that are likely under direct viral influence.
  • NS3 Dominance: NS3 was specifically implicated in the regulation of MGMT, SOCS1, DAPK1, TP53, and WIF1.

Limitations and Future Work

  • Computational Predictions: As with all bioinformatic studies, these results are predictions based on existing literature. They provide a high-confidence "map," but "wet lab" experiments (in vitro and in vivo) are required to confirm these specific interactions in infected liver cells.
  • Functional Ambiguity: The authors note that while they can identify an interaction, it is sometimes difficult to determine if that interaction activates or inhibits a gene without further complex molecular modeling.
  • Future Directions: The researchers suggest these identified pathways—particularly the NS3-mediated ones—should be prioritized for screening new pharmacological agents to prevent HCV-induced liver cancer.

Summary updated

Abstract

Hepatitis C virus (HCV) is a risk factor that leads to hepatocellular carcinoma (HCC) development. Epigenetic changes are known to play an important role in the molecular genetic mechanisms of virus-induced oncogenesis. Aberrant DNA methylation is a mediator of epigenetic changes that are closely associated with the HCC pathogenesis and considered a biomarker for its early diagnosis. The ANDSystem software package was used to reconstruct and evaluate the statistical significance of the pathways HCV could potentially use to regulate 32 hypermethylated genes in HCC, including both oncosuppressor and protumorigenic ones identified by genome-wide analysis of DNA methylation. The reconstructed pathways included those affecting protein-protein interactions (PPI), gene expression, protein activity, stability, and transport regulations, the expression regulation pathways being statistically significant. It has been shown that 8 out of 10 HCV proteins were involved in these pathways, the HCV NS3 protein being implicated in the largest number of regulatory pathways. NS3 was associated with the regulation of 5 tumor-suppressor genes, which may be the evidence of its central role in HCC pathogenesis. Analysis of the reconstructed pathways has demonstrated that following the transcription factor inhibition caused by binding to viral proteins, the expression of a number of oncosuppressors (WT1, MGMT, SOCS1, P53) was suppressed, while the expression of others (RASF1, RUNX3, WIF1, DAPK1) was activated. Thus, the performed gene-network reconstruction has shown that HCV proteins can influence not only the methylation status of oncosuppressor genes, but also their transcriptional regulation. The results obtained can be used in the search for pharmacological targets to develop new drugs against HCV-induced HCC.
BibTeX
@inproceedings{2023computer,
  author = {Е. А. Ощепкова and Т. М. Хлебодарова and П. С. Деменков and A. S. Venzel and Nikita V. Ivanisenko and Alexandr D. Gavrilenko and Timofey Ivanisenko and A. V. Adamovskaya and Polina M. Revva and Inna N. Lavrik and В. А. Иванисенко},
  title = {{Computer analysis of regulation of hepatocarcinoma marker genes hypermethylated by HCV proteins}},
  booktitle = {Vavilov},
  year = {2023},
  doi = {10.18699/vjgb-22-89},
}
Figure